Distinguishing among incretin-based therapies. Glucose-lowering effects of incretin-based therapies.

Campbell, R Keith

Distinguishing among incretin-based therapies. Glucose-lowering effects of incretin-based therapies. [electronic resource] - The Journal of family practice Sep 2010 - S10-9 p. digital

Publication Type: Case Reports; Journal Article

1533-7294


Adamantane--analogs & derivatives
Aged
Blood Glucose
Diabetes Mellitus, Type 2--drug therapy
Dipeptides--therapeutic use
Dipeptidyl-Peptidase IV Inhibitors--administration & dosage
Exenatide
Female
Glucagon--metabolism
Glucagon-Like Peptide 1--agonists
Glucagon-Like Peptide-1 Receptor
Glycated Hemoglobin--metabolism
Humans
Hypoglycemic Agents--administration & dosage
Incretins--pharmacology
Insulin--metabolism
Insulin Resistance
Liraglutide
Male
Metformin--therapeutic use
Middle Aged
Peptides--therapeutic use
Pyrazines--therapeutic use
Receptors, Glucagon
Sitagliptin Phosphate
Triazoles--therapeutic use
Venoms--therapeutic use